Clinical Trial Update: A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/II neoadjuvant trial evaluating zolbetuximab with docetaxel, oxaliplatin and S-1 in locally advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)
• Taxotere (docetaxel)
• Zolbetuximab (zolbetuximab)

Snippet

Sponsor: Asan Medical Center | Conditions: Stomach Neoplasm, Gastric (Stomach) Cancer | Phase 1, Phase 2 | Status: RECRUITING